STAT May 19, 2020
Matthew Herper

The Food and Drug Administration said Tuesday that it will launch a new research project focused on real-world evidence — data collected by insurance companies, in electronic health records, and in other places in medicine — to learn more about Covid-19, including how diagnostics and medications are being used in the pandemic and how best to design studies to test them.

The project is a collaboration with Aetion, a New York health tech startup that specializes in real-world evidence.

“Right now, I think that the most intriguing part of the Aetion story is the ability to have a very consistent analytic approach that can be applied across multiple datasets,” Amy Abernethy, the FDA’s principal deputy commissioner, said in an interview....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: EMR / EHR, FDA, Govt Agencies, Health IT, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Technology
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
FDA approves Merck drug for rare lung disorder
Neuronetics wins FDA clearance for device to treat adolescents with depression
FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval

Share This Article